Retatrutide Just Reached Bariatric Surgery Results
From On The Pen GLP-1 News · · 48 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Dave sits down with nurse practitioner and former Retatrutide clinical trial participant David White to break down the biggest obesity headlines from the 2026 American Diabetes Association Conference. Together, they explore the latest data on Retatrutide's potential to deliver bariatric surgery-level weight loss, improve cardiometabolic health, and reshape the future of obesity and type 2 diabetes treatment.
otplinks.com